Metopon (cas 143-52-2) and two unique derivatives: affinity and selectivity for the multiple opioid receptors

Add time:09/29/2019    Source:infona.pl

5β-Methyl-7,8-dihydromorphinone (Metopon (cas 143-52-2)), an isomer [6a S-(6aα,9aα,10β)13a S]-1,10-methano-4-hydroxy-11-methyl 6,6a,8,9,10,11,12,13-octahydro-[1]-benzopyrano[4,3,e]isoquinoline-7-(9a H)-one (compound 1) derived from a photochemical rearrangement of 5β-methylmorphinone, and [6a S-(6aα,9aα,10β)13a S]-1,10-methano-4-hydroxy-11-methyl-6,6a,8,9, 10,11,12,13-octahydro-[1]-benzopyrano[4,3,e]-14β-(p-nitrocinnamoylamino) isoquinoline-7-(9a H)-one (compound 2) were characterized for opioid receptor affinity, selectivity and analgesic properties. In competition binding assays using bovine striatal membranes, the three compounds inhibited the binding of 0.25 nM [ 3 H][d-Ala 2 ,(Me)-Phe 4 ,Gly(ol) 5 ]enkephalin (DAMGO), a μ-selective peptide, with IC 50 values less than 5 nM. All three compounds exhibited lower affinity for δ- and κ-opioid receptors. In the mouse 55 °C warm-water tail-flick assay, both metopon and compound 1 displayed antinociception that lasted for 60 min after i.c.v. injection. Morphine sulfate, metopon and compound 1 produced 50% antinociception with i.c.v. doses of 0.83, 2.0 and 4.0 nmol, respectively. The μ-selective, irreversible opioid receptor antagonist β-funaItrexamine blocked antinociception induced by metopon and compound 1, while δ- and κ-opioid receptor selective antagonists did not effect antinociception. These findings demonstrate metopon and its isomer bound with high affinity to the μ-opioid receptor and produced antinociception through this receptor.

We also recommend Trading Suppliers and Manufacturers of Metopon (cas 143-52-2). Pls Click Website Link as below: cas 143-52-2 suppliers

Prev:14β-Chlorocinnamoylamino derivatives of Metopon (cas 143-52-2): long-term μ-opioid receptor antagonists
Next:LC-MS-MS Method for the Determination of PROTOVERATRINE A (cas 143-57-7) in Rat Plasma)